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The Hedgehog (Hh) signaling pathway plays critical instructional roles during embryonic development. Misregulation of Hh/Gli signaling is a
major causative factor in human congenital disorders and in a variety of cancers. The zebrafish is a powerful genetic model for the study of Hh
signaling during embryogenesis, as a large number of mutants that affect different components of the Hh/Gli signaling system have been
identified. By performing global profiling of gene expression in different Hh/Gli gain- and loss-of-function scenarios we identified known
(e.g., ptc1 and nkx2.2a) and novel Hh-regulated genes that are differentially expressed in embryos with altered Hh/Gli signaling function. By
uncovering changes in tissue-specific gene expression, we revealed new embryological processes that are influenced by Hh signaling. We thus
provide a comprehensive survey of Hh/Gli-regulated genes during embryogenesis and we identify new Hh-regulated genes that may be targets of
misregulation during tumorigenesis.
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roles during embryonic development. Across many species,
secretedHh proteins provide critical instructional cues that induce
and pattern a wide range of embryonic tissues. In humans, inap-
propriate Hh signaling results in diverse developmental defects
and is implicated in the induction, maintenance, and/or metastasis
of up to 25% of human brain tumors [1,2].
One key feature of the Hh pathway is the versatility of the
signal. In the developing central nervous system (CNS), Sonic Hh
(Shh), one of the three Hh proteins so far described in vertebrates,
acts as a morphogen to regulate expression of a series of
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doi:10.1016/j.ygeno.2007.09.001identity. In addition to this role in cell fate decisions, Shh signaling
also modulates neural progenitor proliferation and survival in the
developing neural tube [3] and regulates stem cell maintenance
within the embryonic and adult dorsal brain [4,5]. Recent studies
have also implicated Shh directly in axon guidance, suggesting
that localized Hh signaling affects cellular behaviors independent
of a transcriptional response [6,7]. Hh proteins act through the
transmembrane proteins Patched (Ptc) and Smoothened (Smo) to
trigger an intricate cytoplasmic transductionmachinery, ending in
the downstream activation of the Gli family of transcription
factors. In vertebrates, at least three Gli proteins (Gli1, Gli2, and
Gli3) that are homologous to the single Drosophila Cubitus
interruptus (Ci) gene [8] have been described. Extensive research
has focused on understanding how Hh signals, transduced by
Smo, regulate the activity of the three Gli proteins and on how this
signaling determines the magnitude and quality of the resultant
Hh-dependent target gene induction [9,10]. Gli proteins are zinc
finger transcription factors that respond to Hh signals and then
Table 1
Global data on identification of Hh-regulated genes by microarray analysis
Experiment Up-regulated genes Down-regulated genes
Total % novel Total % novel
smu vs WT 245 81 376 83
dtr vs WT 367 84 455 81
shh injected vs WT 203 80 163 72
Gene expression was analyzed using microarrays representing a set of 34,647
transcripts. Genes showing a greater than twofold up- or down-regulation were
tallied.
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expression (Class II Hh-responsive genes such as nkx2.2a and
ptc1) or repressing expression (Class I Hh-responsive genes
such as pax7 and dbx2) [11]. Gli1 acts primarily as an activator,
while Gli2 and Gli3 can act both as activators and as repressors,
like Ci. In mammals Gli2 appears to be the major activator of Hh
signaling in the ventral nervous system, while in zebrafish Gli1 is
the major activator and Gli2 plays both activator and repressor
roles in different regions of the CNS [12]. The current model
suggests that a combinatorial “code” ofGli repressor and activator
functions guides Hh-mediated cell proliferation and differentia-
tion in the vertebrate embryo.
Recent evidence provided by Cayuso and colleagues [3]
shows that Shh-regulated patterning, proliferation, and survival
of progenitors are separable activities in the developing spinal
cord, suggesting that each of these cellular properties is an
independently regulated response to Shh/Gli signaling. Thus,
Shh signaling appears to directly coordinate the growth and
patterning of the developing neural tube through Gli-mediated
transcriptional regulation of discrete sets of target genes, in-
cluding members of the homeodomain protein and basic helix-
loop-helix (bHLH) families such as nkx2.2a and foxA2 [3].
Since Hh signaling can influence multiple developmental pro-
cesses, the genes that are activated or repressed in each cir-
cumstance vary with cellular context and developmental time,
and Hh-mediated gene regulation is likely to require cell-type-
specific cofactors. To date, a handful of genes whose tran-
scription is regulated directly by Hh/Gli signaling have been
described in both mammals and teleosts [11,13] and analyses
of their promoter regions have led to the identification of a
consensus Gli binding motif within their regulatory sequences
[14,15]. These genes are known to regulate a variety of cellular
processes including proliferation, metabolism, and apoptosis
[16]. Considering the multitude of developmental processes that
are regulated by Shh signaling, we hypothesize that there are far
more Hh target genes than have been characterized to date that
allow the reiterative deployment of the Shh pathway to elicit
such diverse cellular responses. While the task of determining
the repertoire of direct targets of transcription factors is still
daunting, especially for organisms with complex genomes,
microarray profiling of gene expression has emerged as a
powerful approach for identifying regulatory networks of genes.
To uncover global changes in gene regulation in the embryo,
appropriate gain- and loss-of-function scenarios are needed.
Fortunately, large-scale genetic screens have identified a
number of zebrafish mutations that affect embryonic develop-
ment by disrupting different components of the Hh signaling
cascade [17,18]. Among these are slow-muscle omitted (smu),
which inactivates the Smoothened receptor and blocks all Hh
signaling [19–21], and detour (dtr), which inactivates Gli1, the
main Hh effector in zebrafish [12].
We used thesemutants to globally characterize transcriptional
changes that result from altered Hh/Gli signaling in the ver-
tebrate embryo. Using a microarray approach, we compared the
transcriptional profiles of wild-type embryos to those of smu
(smo) and dtr (gli1) mutant embryos and to embryos with
hyperactivated Hh signaling following shh mRNA injection.This strategy has allowed us to (1) identify known genes that
may be direct or indirect targets of Hh/Gli signaling and (2)
uncover novel roles for Hh signaling in known developmental
processes.
Results and discussion
Microarray analysis
Changes in the transcriptional profiles were analyzed by
microarray using a set of oligonucleotides representing 34,647
transcripts. Table 1 gives an overview of the number of tran-
scripts that showed positive and negative regulation by Hh,
while Supplemental Table S1 contains the complete list of genes
on the microarray chips and the observed regulation by Hh
signaling. Some of these genes have been previously linked to
Hh signaling, while others have no reported Hh regulation
(Fig. 1A). We also detected many genes of unknown function
that respond to Shh, characterized only as ESTs (Fig. 1B). A
similar microarray study was recently published that also
identified a large number of Hh-regulated genes [22]. In this
previous study by Xu et al., injection of mRNA encoding a
dominant negative form of protein kinase Awas used to mimic
Hh activation [22], while loss of Hh signaling was induced by
cyclopamine treatments. In contrast, our study used shh mRNA
injections to induce Hh signaling, and loss of Hh signaling was
examined using known Hh pathway mutants, providing a more
direct manipulation of Hh signaling. Of 37 Hh-regulated genes
with putative Gli binding sites found by Xu et al. [22], 13
showed similar regulation by Hh in our microarray analysis, 3
showed opposite regulation, and 21 showed no significant
regulation by Hh signaling. Similarly, 14 genes were verified for
Hh regulation by Xu et al., and of these, 12 showed similar
regulation in our study (see Supplemental Table S1). This
comparison indicates that the two methods effectively identified
an overlapping set of Hh-regulated genes. While discrepancies
in the results may indicate inconsistencies in the microarray
analysis, they may also point to real differences in regulation that
are due to the different methods of manipulating Hh signaling.
We analyzed the expression of a subset of genes from three
categories (known Hh target genes, known genes but unknown
as Hh targets, and novel genes) using whole-mount in situ
hybridization (ISH). Table 2 shows a summary of the genes
analyzed in this paper, the data obtained for them in the
Fig. 1. Expression profiles of selected significantly up-regulated or down-regulated genes in embryos with altered Hh signaling. For each treatment, four replicate
hybridizations were performed. The pattern of differential expression (median log 2 ratio) is graphically presented. (A) We chose 11 known genes and evaluated their
expression profile in the different treatments. Among previously identified Shh-regulated direct targets, both ptc1 and nkx2.2a are included and show the expected
modulation. Also, 9 novel candidate Shh target genes were chosen based on their implication in cell growth and differentiation. These selected genes were
independently confirmed as Shh target genes by whole-mount in situ hybridization. (B) We show 8 novel genes/ests that change their expression in the different
treatments. Some of these genes were confirmed by in situ hybridization.
167S.A. Bergeron et al. / Genomics 91 (2008) 165–177microarray assay, and whether regulation by Hh was verified by
ISH. This microarray analysis could potentially identify direct
transcriptional targets of Hh regulation as well as genes that were
indirectly up- or down-regulated due to changes in tissue
differentiation. To begin to identify which genes might be
directly regulated by Hh, we scanned genomic sequences up to
5 kb upstream of the translational start site and 5 kb downstream
of the translational stop for putative Gli transcription factor
binding sites (GACCACCCA), as previously done by Xu et al.
[22]. As shown in Table 2, 15 of 28 genes analyzed had at least
two Gli binding sites in this region, suggesting they may be
direct Hh/Gli transcriptional targets.
Verification of Hh regulation by whole-mount in situ hybridization
Changes in Hh signaling could affect overall gene expres-
sion levels in the embryo directly through changes in Gli-
mediated transcriptional regulation (e.g., Class I and Class II
Hh-responsive genes), indirectly through regulation of other
transcription factors, or indirectly through global changes in the
development of embryonic tissues [23]. To assess the relevanceof our data we thus decided to verify the gene regulation data
obtained from the microarray using whole-mount ISH. In
addition to allowing a relatively rapid verification of gene
expression in different Hh-manipulated embryos, this approach
provided spatial information and insights about the nature of
regulation by Hh signaling. In the process, this approach also
revealed new information about the role of Hh signaling in
organogenesis. We immediately recognized several known Hh
target genes among the genes showing regulated expression on
the microarray. The well-characterized Hh receptor ptc1, as
well as the early transcriptional target nkx2.2a, were appropri-
ately regulated on the chip [24,25]. These data confirmed that
our approach could identify direct Hh transcriptional targets.
We next examined known developmental genes that were not
previously reported to be regulated by Hh (e.g., Figs. 2–4). We
also examined the expression of previously uncharacterized
genes to determine whether gene expression differences seen on
the microarray were reflected by differential expression in the
embryo. Gene-specific primers based on published ESTs and
genomic sequences (see Supplemental Table S1) were used to
amplify coding regions from first strand cDNA, and antisense
Table 2
Summary of genes analyzed
Values indicate fold change in gene expression seen on the microarray for each Hh manipulation, relative to wild type and uninjected controls. Numbers in parentheses show
regulation of the same gene represented by an independent position on the chip. Dark green (increased expression) or red (decreased expression) shading indicates twofold
change in expression, while lighter red or green shading indicates regulation slightly below this twofold cutoff. ISH, in situ hybridization; n.d., no data; pGBS, number of
putative Gli binding sites; shh-inj., sonic hedgehog overexpression by mRNA injection. (For interpretation of the references to colour in this table legend, the reader is referred
to the web version of this article.)
1NM_131422_1 (X85977), 2X98883, 3AF442964, 4AF014370, 5AF198086, 6AF084948 (NM_131037_1), 7NM_131046, 8AF359426 (NM_131763), 9AY017308,
10AF036148, 11NM_131277_1 (AF014366).
168 S.A. Bergeron et al. / Genomics 91 (2008) 165–177RNA probes were made directly from PCR-amplified products.
Twenty two novel genes that showed regulation by microarray
analysis were chosen for further analysis based on bioinfor-
matic analysis suggesting they might play a role in embryo-
genesis. We were able to generate ISH probes for 16 of the 22
selected genes, and of these, 8 displayed appropriate regulation
in mutant and/or shh mRNA-injected embryos.
Positively regulated known genes
follistatin (fst; GenBank Accession No. AF084948) and
follistatin-like2 (fstl2; GenBank Accession No. A159257)
regulation by Shh suggests a new regulatory mechanism for BMP
signaling
Our microarray results indicated that follistatin (fst) expression
was significantly up-regulated following shh mRNA injection
(2.8× increase). Expression in smu (smo) mutants was reduced, butat a level that just missed the twofold cutoff for significance on one
of two microarray spots (0.6×). fst expression was relatively
unchanged in dtr (gli1) mutant embryos (0.8×) (Table 2). An
uncharacterized EST (fc25c04) related to follistatin-like2 also
showed positive regulation by Hh (2.2× in shh mRNA-injected
embryos and 0.3× in smu (smo) mutants). fst is a well-known bone
morphogenic protein (BMP) antagonist that is expressed in axial
and paraxial mesoderm during late gastrula stages in zebrafish as
well as later in the somites, brain, and eye [26]. fst was shown
previously to inhibit a number of vertebrate BMPs including
BMP2, BMP4, BMP5, and BMP7 [27,28]. Experiments in chick
showed that fst can modulate the effects of BMP on Hh signaling,
making neural progenitor cells more responsive to Hh signals and
enhancing Hh-mediated differentiation into ventral cell types [29].
While it is known that a gradient of BMP signaling opposes theHh
signaling gradient in the neural tube, regulation of fst byHh has not
previously been demonstrated.
Fig. 2. Confirmation that follistatin (fst) and follistatin-like2 (fstl2;wu: fc25c04) expression is affected by Hh signaling. (A) In wild-type embryos, fst is regionally expressed in
the CNS,with weak dorsal expression in the region of the epiphysis (left arrowhead), tectum (right arrowhead), and hindbrain (thin arrows). fst is also expressedmore ventrally
in the diencephalon (arrow), midbrain, and hindbrain (white bracket). In the trunk, fst is expressed in ventral and dorsal regions of somites, but expression is undetectable in the
dorsal spinal cord (insets, arrowheads). (B) In shhmRNA-injected embryos, dorsal fst expression is expanded in the diencephalon and midbrain (arrowheads), hindbrain (thin
arrows), and spinal cord (insets, arrows). Ventral fst expression appears mildly reduced in the diencephalon (large arrow) and is reduced in the ventral midbrain and hindbrain
(white bracket). (C) In smu (smo) mutant embryos, fst expression is lost in the dorsal brain (arrowheads) and reduced in the diencephalon (arrow), ventral midbrain, and
hindbrain (white bracket) and somites (insets, arrowheads). (D) In dtr (gli1) mutant embryos, fst expression in the brain is similar to that in wild-type embryos, but may be
slightly reduced in the somites (inset). Regional loss of nkx2.2a expression (red in D and H) confirms that this embryo is a homozygous dtr (gli1) mutant [12]. (E) fstl2 is
expressed in the ventral diencephalon (large arrow), in the ventral midbrain (arrowheads), and in stripes in the hindbrain that may correspond to rhombomere borders (small
arrows). In the trunk fstl2 is expressed dorsally and laterally in the somites (insets, arrowheads). (F) In shhmRNA-injected embryos, fstl2 expression is regionally expanded in
the ventral midbrain (arrowheads) but is mildly reduced in the somites (insets). (G) In smu (smo) mutants fstl2 expression is regionally absent in the forebrain (arrow) and
midbrain (arrowheads) but is expanded in the somites (insets). (H) In dtr (gli1) mutants CNS expression is reduced, while somite expression appears normal.Main panels show
lateral views of 24-hpf zebrafish heads, eyes removed, anterior to the left. The corner insets show lateral views of the trunk, while themedial insets show cross sections through
the trunk. In this and subsequent figures, the numbers in each panel indicate fold change in gene expression from microarray analyses. Fb, forebrain; mb, midbrain; hb,
hindbrain.
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dramatically increased in the dorsal spinal cord and brain in shh
mRNA-injected embryos (Fig. 2). fst expression was reduced inthe same dorsal regions in smu (smo) mutants and slightly
reduced in dtr (gli1) mutants, consistent with positive regulation
by Hh. The microarray analysis failed to uncover differential
Fig. 3. Hh signaling affects ff1b and wilms' tumor 1a (wt1a) expression. (A–D) Ventral views of the heads of 24-hpf zebrafish embryos showing expression of ff1b in the
optic stalk region of the forebrain (arrows). Forebrain ff1b expression is reduced in shhmRNA-injected (B) and smu (smo) mutant embryos (C) and appears slightly reduced
in dtr (gli1) mutants (D). (A′–D′) Ventral views of the trunk between somites I and III showing ff1b expression in the interrenal gland primordia [66]. Additional ff1b-
expressing cell clusters are present in shh mRNA-injected embryos (B′, arrowheads). Interrenal gland ff1b expression is absent in smu (smo) mutants (C′) and is slightly
reduced in dtr (gli1) mutants (D′). (A″–D″) Ventral views of the trunk between somites I and III showing bilateral expression of wt1a in the developing pronephros [65].
wt1a expression is expanded in shh mRNA-injected embryos (B″ outside circle) and reduced in smu (smo) and dtr (gli1) mutants (C″ and D″, within circles). The circles
represent the domain of wild-type wt1a expression.
170 S.A. Bergeron et al. / Genomics 91 (2008) 165–177expression of fst in smu (smo) mutants, most likely for technical
reasons. fstl2 was reduced ventrally and in the forebrain of smu
(smo) mutants but increased elsewhere in the somites (Fig. 2),
which may account for the almost unchanged overall expression
detected on the microarray (0.9×). Regulation of fst expression
by Hh could be direct, as the promoter region contains a
putative Gli binding site (GAACACCCA) that has a 1-bp dif-
ference compared to the Gli binding site found in the human
ptc1 promoter (GACCACCCA) [22]. These results suggest
that Hh signaling helps regulate expression of these BMP
antagonists and may point to a new regulatory mechanism bywhich antagonistic BMP and Shh signaling gradients are
balanced to establish proper dorsal/ventral neural patterning.
ftz-f1 (ff1b, nr5a1a; GenBank Accession No. AF198086) and
wilms' tumor 1a (wt1a; GenBank Accession No. X85734)
regulation points to a role for Hh in interrenal gland and
pronephros development
Our microarray data suggested that expression of the ftz-f1
nuclear receptor homolog ff1b and of wilms' tumor 1a (wt1a) is
highly influenced by Hh signaling. Both ff1b and wt1a are
down-regulated in smu (smo) and dtr (gli1) mutants and up-
171S.A. Bergeron et al. / Genomics 91 (2008) 165–177regulated in shh mRNA-injected embryos (ff1b 0.20×, 0.20×,
and 3.75×; wt1a 0.26×, 0.29×, and 2.36×, respectively). ff1b is
the apparent ortholog of mammalian SF1, an orphan nuclear
hormone receptor transcription factor required for adrenal gland
(interrenal gland in zebrafish [30]) organogenesis [31]. wt1a is a
zinc finger transcription factor required for the proper formation
of the vertebrate kidneys (pronephros in zebrafish) and the
mammalian gonads [32]. It was previously shown that loss of
wt1a function in zebrafish disrupts midline fusion of lateral
pronephric cells and also results in a reduction in ff1b expression
in the adjacent interrenal cells, suggesting a tight link between
interrenal and pronephric development [33]. Therefore, dimin-
ished ff1b expression in Shh pathway mutants could be an
indirect effect of the loss of wt1a expression. Hh signaling from
the overlying notochord has also been implicated in pronephros
and adrenal gland development [31,34], but regulation of these
genes by Hh has not previously been demonstrated.
ISH analysis verified the changes in ff1b and wt1a expression
levels seen by microarray (Fig. 3). In the trunk, interrenal gland
expression of ff1b was absent in smu (smo) mutants (Fig. 3C′)
and significantly reduced in dtr (gli1) mutants (Fig. 3D′), with
apparently fewer cells expressing the gene. ff1b expression may
be increased in shh mRNA-injected embryos because expres-
sion was expanded to as many as four distinct clusters of cells
(Fig. 3B′). Similarly, wt1a expression in the pronephric primor-
dia was significantly reduced in smu (smo) and dtr (gli1)
mutants and was expanded in shh mRNA-injected embryos
(Figs. 3B″, C″, and D″). ff1b expression was also reduced in the
forebrain of smu (smo) and dtr (gli1) mutants (Figs. 3C, D).
Interestingly, shh mRNA injection also reduced forebrain ff1b
expression (Fig. 3B). The fact that both excess and reduced Hh
signaling reduces expression of ff1b in the forebrain suggests
that these ff1b-expressing cells may require an optimal, middle
level of Hh signaling to differentiate. In shh-injected embryos,
increased expression of ff1b in the trunk appears to overshadow
this loss of forebrain expression to produce the overall increase
in expression seen in the microarray experiments.
Despite the lack of ff1b in smu (smo) mutants (Fig. 3C), the
interrenal primordia are able to form, as indicated by expression
of the steroidogenic tissue marker cyp11a1 (scc) in these mutants
[33]. This suggests ff1b is not required for scc expression, as had
been suggested by ff1b knockdown experiments in zebrafish [35].
Our ISH analyses suggest that Hh signaling plays an important role
in interrenal and pronephric primordia development. This role for
Hh appears to be evolutionarily conserved, as mice expressing a
dominant-negative form of the Hh-responsive transcription factor
Gli3 do not develop adrenal glands [36]. Our data may help direct
further investigations into the link betweenHh signaling, interrenal
ff1b expression, and pronephric wt1a expression during organo-
genesis of the adrenal gland and kidney.
iroquois 1b (irx1b; GenBank Accession No. AY017308):
possible feedback between irx genes and the Hh pathway
Our microarray data showed a down−regulation of irx1b
expression in both smu (smo) and dtr (gli1) mutants (0.36×
and 0.5×, respectively). The irx genes are highly conserved
homeodomain transcription factors that have been implicated inthe patterning of diverse tissues during development, such as the
dorsal head and notum of Drosophila and the neural plate and
heart in vertebrates (reviewed by Cavodeassi and colleagues
[37]). Previously, regulation of irx genes by Hedgehog signaling
has been shown in flies, chicks, and frogs. Patterning of the
larval wing disc in Drosophila involves activation of iro-C
complex genes by Hh/Ci signaling [38]. The Xenopus Xiro1
gene is strongly activated in the anterior neural plate by over-
expression of Ci [39]. In the chick as well as in the zebrafish,
irx3, together with other homeodomain transcription factors,
affects dorsoventral patterning of the neural tube [11]. irx3 is a
Class I gene, repressed by Shh, and its expression domain defines
the region where V2 neurons will form in the ventral neural tube.
Conversely, irx1a can regulate Shh itself, as seen in the de-
veloping zebrafish [40], suggesting a feedback loop between
these genes. Whether the relationship between Hh signaling and
the iroquois genes is direct or indirect remains to be determined.
irx1b expression inwild−type embryos is restricted to theCNS
at 24 hours postfertilization (hpf), including the dorsal dienceph-
alon and midbrain, hindbrain, cerebellum, lateral floor plate, and
spinal cord (Fig. 4A, [41]). ISH analysis verified that irx1b is
down-regulated in smu (smo) mutants, with expression regionally
lost in the midbrain and generally reduced in the tail (Fig. 4C).
irx1b expression was similarly reduced in dtr (gli1) mutant
embryos (data not shown), consistent with the reduction seen on
the microarray. While no overall change due to shh mRNA
injection was seen on the microarray or by ISH, subtle regional
changes in irx1b expression were detected in shh-injected
embryos (Fig. 4B). Most notably, the expression domain
encompassing the posterior diencephalon and anterior midbrain
was expanded.
claudin b (cldnb; GenBank Accession No. NM_131763)
indicates Shh modulation of genes in the otic placode
cldnb was significantly down-regulated in smu (smo) and dtr
(gli1) mutant embryos (0.47× and 0.41×, respectively), with little
change seen in shh-injected embryos. Claudins are members of
the tetraspanin superfamily of integralmembrane proteins specific
to vertebrates that participate in cellular adhesion and migration
and form vertebrate tight-junction strands [42] in various em-
bryonic and adult structures [43]. In mammals, the family
comprises at least 20members, and genetic lesions in claudins are
known to be the cause of defects such as kidney Mg2+ resorption
[44] and deafness [45]. In zebrafish, cldnb is expressed in the
developing ear and in lateral-line placodes, olfactory placodes,
and pronephric duct and subsequently in the lateral line primordia,
with cldnb being expressed strongly in the migrating primordia
and in all neuromast accessory cells [46].
Our ISH analysis confirmed the down-regulation of cldnb in
smu (smo) mutant embryos at 24 hpf, with expression completely
absent (Fig. 4F). cldnb expression appeared normal in dtr (gli)
mutants (data not shown). Consistent with the microarray results,
cldnb expression levels in shh-injected embryos resembled those
seen in wild-type embryos, despite the change in otic vesicle
morphology (Fig. 4E). Since otic placode morphology appears
normal in smu (smo) mutants (Fig. 4F), the loss of cldnb
expression in these mutants may represent specific regulation by
172 S.A. Bergeron et al. / Genomics 91 (2008) 165–177Hh. This analysis is the first to suggest regulation of cldnb by Hh
activity.
neuroD (nrd; GenBank Accession No. AF036148): a proneural
gene regulated by Shh
Our microarray analysis showed a decrease in nrd expression
in smu (smo) mutants (0.47×) and no significant changes in shh-
injected embryos (0.89×). nrd is a bHLH transcription factor
expressed during neurogenesis [47] that is also required for
pancreatic morphogenesis in mice [48]. In 24-hpf zebrafish nrd is
expressed in the dorsal forebrain and ventral midbrain/hindbrain,
as well as in the pancreas, lateral line placodes, the facial
epibranchial placode, and the octaval/statoacoustic ganglion
precursors (Fig. 4G, [49]).
ISH analysis confirmed the microarray results, showing a
regional loss in nrd expression in smu (smo) mutants and regional
changes in shh mRNA-injected embryos. In particular, nrd
expression was lost in smu (smo) mutants in the anterior/ventral
hindbrain, as well as in the pancreas (Fig. 4I). In shh mRNA-
injected embryos, nrd expression was expanded in the dorsal
forebrain, as well as in the pancreas (Fig. 4H). This analysis
uncovers Hh regulation of nrd expression in several regions of the
embryo. We were unable to identify a Gli motif in the nrd
promoter within 5 kb 5′ of the translation start site, possibly
indicating that this regulation by Hh signaling is indirect.Fig. 4. irx1b, claudinB, and neuroD expression in embryos with altered Hh signal
embryos irx1b is expressed regionally in the midbrain, hindbrain, and spinal cord an
embryos, irx1b expression is reduced in the tectum (arrowhead), but expression in the
also slightly expanded in the caudal spinal cord (arrow in inset). (C) irx1b expressio
cord (arrow in inset). (D) In wild-type embryos claudinB is expressed in the otic pla
throughout the entire otic placode. (F) In smu (smo) mutants claudinB expression is
telencephalon and diencephalon of the forebrain (arrows), in the ventral hindbrain (arr
mRNA-injected embryos dorsal neuroD expression is expanded, and expression in
neuroD expression is extremely reduced in smu (smo) mutants, including in the
represented by more than one oligo on the microarray chip.Negatively regulated known gene: pax3 (GenBank Accession
No. AF014366), a Class I Hh-regulated gene
Microarray analysis revealed that pax3 transcription was
significantly down-regulated in shh mRNA-injected embryos
(0.554×) and somewhat up-regulated in smu (smo) mutants
(1.6×), similar to the known Class I gene pax7 (Table 2).
There was no significant change in pax3 expression in dtr
(gli1) mutants (0.82×). pax3 is part of a family of paired-box-
containing transcription factors that are involved in multiple
developmental processes including neural tube closure,
muscle differentiation, and neural crest cell differentiation
[50]. In zebrafish, pax3 is expressed in the dermomyotome
[51], dorsal diencephalon, and spinal cord [13]. Hh has been
shown to repress pax3 expression in the chick [52] and
zebrafish [53] somite and more recently in the zebrafish neural
tube [13].
ISH confirmed the negative regulation of pax3 by Hh sig-
naling seen in the microarray analysis (Fig. 5). In shh mRNA-
injected embryos, pax3 expression was strongly reduced and
was restricted to the very dorsal regions of the neural tube. In
the absence of Hh signaling (smu (smo) mutants) pax3
expression was expanded into the ventral neural tube.
Consistent with the microarray data, little or no change in
pax3 expression was seen in dtr (gli1) mutants. Since neuraling. (A–C) Lateral views of 24-hpf embryos, eyes removed. (A) In wild-type
d in the caudal region of the notochord (inset) [67]. (B) In shh mRNA-injected
mid-diencephalon boundary is expanded caudally (brackets). irx1b expression is
n is reduced in smu (smo) mutants in the midbrain (arrowhead) and in the spinal
code (bracket). (E) In shh mRNA-injected embryos this expression is expanded
completely absent. (G) In wild-type embryos, neuroD is expressed in the dorsal
owheads), and in the posterior half of the developing pancreas (inset). (H) In shh
the developing pancreas expands anteriorly (inset, bracket and arrowhead). (I)
developing pancreas (inset). Two numbers indicate regulation seen for genes
173S.A. Bergeron et al. / Genomics 91 (2008) 165–177cells are clearly present but fail to express pax3 in smu (smo)
mutants, these data suggest pax3 is transcriptionally regulated
by Hh signaling, either directly via Gli transcriptional regulation
or indirectly via other Hh-regulated transcription factors. An
analysis of the promoter region of pax3 reveals Gli binding
sites, suggesting Hh/Gli signaling may directly repress pax3
expression, helping limit expression to the dorsal neural tube.
These data help define pax3 as a Class I Hh-regulated gene.
Since pax3 expression appears normal in dtr (gli1) mutants
these data suggest that this Hh regulation of pax3may occur via
Gli2 and/or Gli3 repressor activity.
Unknown gene regulated by Shh: novel Hh/Gli-regulated gene
zgc:92916
Our microarray analysis identified over 300 putative Hh-
regulated genes (Table 1). Many of these genes represent ESTs
for which no function has been assigned. We chose to further
examine several of these ESTs by ISH to determine whether
they were indeed regulated by Hh signaling (Table 1) and to
determine where in the embryo they are expressed as a first step
toward a functional analysis. We present detailed data for one of
these genes here.
Our microarray analysis showed that fr71a09.y1 (BI428994),
which corresponds to the gene zgc:92916 in zebrafish, was down-
regulated in smu (smo) mutants (0.18×), and possibly up-
regulated in shhmRNA-injected (1.4×) and relatively unchanged
in dtr (gli1) mutant embryos (1.2×). zgc:92916 is 83% identical to
mouse RAB3C and 90% identical to human Rab3C, a member of
the Ras oncogene family of GTP-binding proteins that are
involved in regulated endocytosis. Another member of this large
protein family is Rab23,which has specifically been implicated asFig. 5. pax3 expression and Hh signaling. (A) In wild-type embryos, pax3 is expres
stopping at the midbrain/forebrain boundary. pax3 is also expressed in somites [64], b
injected embryos, pax3 expression is greatly reduced in the CNS and is restricted to t
(smo) mutants, pax3 expression is expanded ventrally in the midbrain (bracket, arro
(inset, arrowheads). (D) In dtr (gli1) mutants pax3 expression appears normal in th
labeling, bracket, compare to inset) confirms that this embryo is a homozygous dtra negative regulator in the Hh signaling pathway and is involved
in trafficking of Smo in endosomes [54].
ISH analysis confirmed the microarray results. In 24-hpf
wild-type embryos, zgc:92916 is regionally expressed in the
brain and spinal cord (Fig. 6A). In the brain, zgc:92916 is
expressed in the telencephalon, as well as in the anterior dien-
cephalon, tegmentum, and ventral hindbrain, regions where Hh
signaling is known to play an important patterning role.
zgc:92916 expression is regionally reduced in smu (smo) mu-
tants, being mostly absent from the anterior diencephalon and
tegmentum (Fig. 6C). In shhmRNA-injected embryos, zgc:92916
is expanded dorsally in bands within the hindbrain (Fig. 6B),
similar to the Hh-responsive gene ptc1. In the spinal cord
zgc:92916 is expressed in lateral columns of cells that may include
differentiating motoneurons, interneurons, and commissural
neurons. This expression is largely absent in smu (smo) (Fig. 6C)
despite the fact thatmost of these neurons are present. Consistently,
expression of zgc:92916 in the lateral spinal cord appears in-
creased in shh mRNA-injected embryos (Fig. 6B, inset).
Final remarks
Although it is clear that the endpoint in the Hh signaling
transduction cascade is the regulation of diverse target genes, our
present understanding of the number and kinds of genes
regulated is limited. Shh can have multiple effects on adjacent
cell types and distinct effects on the differentiation of a single
cell type at different times. Under either scenario, the iden-
tification of transcriptional changes commanded by Hh
that ultimately govern cell fate decisions is essential. Using a
microarray-based approach, we investigated the molecular
mechanisms by which Shh signalingmodifies the transcriptionalsed in the dorsal spinal cord, hindbrain, and midbrain, with anterior expression
ut this expression is weak relative to CNS expression (inset). (B) In shhmRNA-
he dorsalmost region, while somite expression remains weak (inset). (C) In smu
whead). Somite expression of pax3 is greatly increased in smu (smo) mutants
e brain and spinal cord (right inset). Regional loss of nkx2.2a expression (red
(gli1) mutant. Lateral views of 24-hpf embryos, eyes removed.
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embryos, at which point the body plan has been laid out and Shh
may function in roles other than patterning of the embryonic
axes. Moreover, at this stage, dtr (gli1) mutants do not display
significant tissue loss or necrosis, which could otherwise
preclude the identification of bona fide target genes. This work
complements a recent publication by Xu et al. [22], which
described microarray-based expression profiling after global
repression or activation of Shh signaling. Our study goes further
since we took advantage of well-defined mutant loss-of-function
conditions, and our zebrafish microarray contained twice the
number of probes (34,647 versus 16,000). Moreover, we
included the analysis of dtr (gli1) mutants in our experiments,
aimed at dissecting the specific role of Gli1, the main effector of
the pathway in teleosts. Further experiments will be needed to
sort out whether regulation by Hh signaling is direct or indirect.
Studies of Shh function in a number of organisms have
shown that the same signal can govern cell proliferation,
survival, and fate, alternatives that must be context- and time-
dependent. Given the remarkable network of gene activity
regulated by Shh, this growth factor could function to ensure
that independent mechanisms act on the correct number of
precursors that can then respond to appropriate patterning
signals in diverse structures. The classes of genes identified in
this study correlate well with the possible outcomes of Shh
activity. Genes implicated in cell proliferation, survival, and
differentiation were activated by enhanced signaling, and they
corresponded to a wide variety of cellular processes and
molecular functions (Supplemental Fig. 1).Fig. 6. Expression of novel gene zgc:92916 and confirmation of its regulation by
telencephalon (T), ventral hindbrain (white bracket), anterior/dorsal diencephalon (bl
ventral axis of the spinal cord (insets; A–D). (B) In shh mRNA-injected embryos th
midbrain, and hindbrain. (C) In smu (smo) mutants zgc:92916 expression is reduced i
and spinal cord (inset). (D) The expression of zgc:92916 in dtr (gli1) mutants was sim
show nkx2.2a expression (red) allowing unambiguous identification as a homozygoOur findings support a critical role for Shh in building the
nervous system, confirming the current view that beyond its
classical role in ventral patterning, brain growth is controlled by
the mitogenic action of Shh at later embryonic time points. How
the levels and duration of the Hh signal are integrated/modulated
by the recipient cells depends also on how Hh signaling interacts
with other signaling cascades, and several recent studies have
begun to explore such amechanism at the cellular level [55–57]. A
major challenge in the field is to unravel the complex network of
signaling interactions and to identify common targets susceptible
to regulation by more than one inductive signal, as has been
described for the EGFR [57] and β-catenin [55], key components
of the EGF and canonical Wnt signaling pathways, respectively.
It is now clear that embryonic cell–cell signaling systems
involved in cellular patterning play critical roles in tissue
homeostasis, growth, and cancer [4]. In this sense, tumors can be
seen as abnormal organ development processes that, neverthe-
less, display consistent order, morphogenesis, and patterning
[58]. Our study contributes to the understanding of the role of the
Shh pathway by highlighting some new genes that could be used
as targets for drug development for rational anti-cancer
therapies.
Materials and methods
Zebrafish lines
Wild-type andmutant zebrafish embryosweremaintained at 28 °C as described
in [59] and staged according to [60].Mutant lines usedwere smoothmuscle omitted
(smuhi1640), a loss-of-function smoothened allele [19], and detour (dtrts269), a loss-Hedgehog signaling. (A) In wild-type embryos, zgc:92916 is expressed in the
ack bracket), and ventral midbrain (arrowhead) and bilaterally along the dorsal–
is expression is expanded medially in the spinal cord (inset) and dorsally in the
n the anterior/dorsal diencephalon (black bracket), ventral midbrain (arrowhead),
ilar to that seen in wild-type embryos. The embryo in (D) was double labeled to
us dtr mutant.
175S.A. Bergeron et al. / Genomics 91 (2008) 165–177of-function gli1 allele [12]. Mutants were maintained as heterozygotes and
heterozygous adults were crossed to produce homozygous mutant offspring.
Homozygous mutant individuals were identified by morphological criteria (curled
body axes) and/or defects in nkx2.2a expression (dtr).
mRNA injections
shh mRNAwas synthesized with T7 polymerase from the shh/T7TS plasmid
[61] linearized with BamHI using the mMessage mMachine kit (Ambion). Wild-
type embryos were injected with ∼100 pg of shh mRNA at the one- to two-cell
stage. Injected embryos were incubated at 28 °C until 24 hpf and fixed for in situ
hybridization.
Embryo samples and RNA extraction
Total RNA was isolated from 100 embryos per experimental condition by
placing the embryos in 1 ml Trizol reagent (Invitrogen) in an Eppendorf tube.
Embryos were disrupted by grinding them using pestle tips or by vortexing for
1 min, with 500 mg of glass beads (Sigma), until embryos were clearly disrupted
and then allowing the beads to settle before removing the supernatant. RNAwas
further purified using Qiagen Mini-RNA purification columns by resuspending
the RNA in 50 μl of DEPC-treated H2O and following the manufacturer's
instructions for RNA cleanup.
Microarray analysis
The detailed protocol and normalization procedures were as in [62] and are
available upon request. In brief, first-strand cDNA probes were generated by
incorporation of aminoallyl dUTP and then coupled to the desired fluorochrome
(Cy3 or Cy5). The resulting cDNA probes were purified and concentrated. All
samples were hybridized to the arrays compared to a “reference” RNA sample
(which consisted of embryos pooled from multiple stages of development) and
changes of expression level were determined by comparing the signal intensity
changes compared to the stable reference signal. Each chip contained 34,647
printed oligo elements (Compugen, Operon, and MWG) designed from
zebrafish EST assemblies and representing approximately 20,000 genes,
which represented approximately 60% of the total predicted genes according
to the public Ensembl database. After hybridization, the slides were washed,
dried, and scanned using an Agilent DNA microarray scanner (Agilent
Technologies) at 635 nm (Cy5) and then at 532 nm (Cy3). Fluorescence
intensities were quantified using Agilent feature extraction software (Agilent
Technologies). To ensure that all data were directly comparable, we did two
color hybridizations with one of the colors labeling a reference sample that was
the same for all slides. This normalized any chip-to-chip variability by allowing
us to take the “ratio of the ratios” in any given comparison. Hybridizations were
performed twice, switching the fluorescent labeling to eliminate biases caused
by the labeling process. Samples were normalized using the Lowess calculations
(see Supplemental Fig. 1 for description) and cutoffs for significance were
set at a twofold change in either direction. Oligo sequences were mapped
to multiple databases, including RefSeq, UniGene, Ensembl, and TIGR, and
genomic coordinates to maximally determine gene identity and function.
Data were deposited into searchable FilemakerPro and Excel databases for
analysis.
Whole-mount in situ hybridization
Whole-mount ISH at 24 hpf was performed as described [63], using
digoxigenin-labeled probes (Roche). Embryos were postfixed in 4% parafor-
maldehyde overnight, cleared in 75% glycerol, and photographed using DIC
optics on a Zeiss Axioskop. Available probes included cldnb [46], irx1b [41], fst
[26], nrd [47], pax3 [64], and wt1a [65]. In situ probes to novel genes were
made using PCR-generated DNA fragments that contained the T7 (antisense
primer) or SP6 (sense primer) RNA polymerase binding sites. PCR fragments
were amplified from first-strand wild-type cDNA primed with oligo(dT) or
random hexamer primers (Invitrogen cDNA Kit). Gene-specific primer
sequences are listed in Table S1.Acknowledgments
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